doi: 10.3390/ijms232314564 101 PolitoRLa TorreMEMoscatelliFCibelliGValenzanoAPanaroMAet al
Glutathione Power: One of the key components of this treatment is Glutathione, administered through IV extract
Common approaches include continuous use, 5-days-on/2-days-off schedules, or cycling (e.g., 8-12 weeks on, 2-4 weeks off)
Administration of GSH precursors like cysteine/N-acetylcysteine, glycine and/or glutamic acid will facilitate the synthesis of GSH within each cell of the body including the atherosclerotic plaque, reducing ROS and LDL oxidation, enhancing NO production, and mitigating atherosclerosis and its complications (221229)
Tesamorelin mitigates this through pulsatile release (avoiding the sustained supraphysiological GH levels that direct injection creates), and clinical trials in type 2 diabetic patients showed no significant changes in glucose control